| Accession |
PRJCA022396 |
| Title |
Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers |
| Relevance |
Medical |
| Data types |
Whole genome sequencing
|
| Organisms |
Homo sapiens
|
| Description |
According to GLOBOCAN 2020, lymphoma ranked as the 9th most common cancer and the 12th leading cause of cancer-related deaths worldwide. Traditional diagnostic methods rely on the invasive excisional lymph node biopsy, which is an invasive approach with some limitations. Most lymphoma patients are diagnosed at an advanced stage since they are asymptomatic at the beginning, which has significantly impacted treatment efficacy and prognosis of the disease. |
| Sample scope |
Multiisolate |
| Release date |
2024-01-03 |
| Publication |
| PubMed ID |
Article title |
Journal name |
DOI |
Year |
| 38313801
|
Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers
|
Frontiers in Oncology
|
10.3389/fonc.2024.1341997
|
2024
|
| 40597857
|
Early assessment of therapeutic efficacy in lymphoma patients via a blood-based multi-omics response monitoring test
|
BMC Cancer
|
10.1186/s12885-025-14457-6
|
2025
|
| 39740056
|
A Cost-Effective Two-Step Approach for Multi-Cancer Early Detection in High-Risk Populations
|
Cancer Research Communications
|
10.1158/2767-9764.CRC-24-0508
|
2025
|
|
|
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Mao
Mao (maomao@seekin.onaliyun.com)
|
| Organization |
Shenzhen SeekIn Inc |
| Submission date |
2023-12-26 |
